NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006-.

Cover of Drugs and Lactation Database (LactMed)

Drugs and Lactation Database (LactMed) [Internet].

Show details

Telbivudine

Last Revision: June 15, 2020.

Estimated reading time: 1 minute

CASRN: 3424-98-4

image 135115725 in the ncbi pubchem database

Drug Levels and Effects

Summary of Use during Lactation

Telbivudine has not been studied in nursing mothers being treated for hepatitis B infection. An alternate drug may be preferred, especially while nursing a newborn or preterm infant.

No difference exist in infection rates between breast-fed and formula-fed infants born to hepatitis B-infected women, as long as the infant receives hepatitis B immune globulin and hepatitis B vaccine at birth. Mothers with hepatitis B are encouraged to breastfeed their infants after their infants receive these preventative measures.[1,2]

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

Alternate Drugs to Consider

(Hepatitis B) Interferon Alfa, Lamivudine, Tenofovir

References

1.
Visvanathan K, Dusheiko G, Giles M, et al. Managing HBV in pregnancy. Prevention, prophylaxis, treatment and follow-up: Position paper produced by Australian, UK and New Zealand key opinion leaders. Gut. 2016;65:340–50. [PubMed: 26475631]
2.
Dionne-Odom J, Tita AT, Silverman NS. #38: Hepatitis B in pregnancy screening, treatment, and prevention of vertical transmission. Am J Obstet Gynecol. 2016;214:6–14. [PubMed: 26454123]

Substance Identification

Substance Name

Telbivudine

CAS Registry Number

3424-98-4

Drug Class

Breast Feeding

Lactation

Antiviral Agents

Nucleic Acid Synthesis Inhibitors

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

Views

Related information

Similar articles in PubMed

  • Review Adefovir[Drugs and Lactation Database (...]
    Review Adefovir
    . Drugs and Lactation Database (LactMed). 2006
  • Review Entecavir[Drugs and Lactation Database (...]
    Review Entecavir
    . Drugs and Lactation Database (LactMed). 2006
  • Review Lamivudine[Drugs and Lactation Database (...]
    Review Lamivudine
    . Drugs and Lactation Database (LactMed). 2006
  • Review Emtricitabine[Drugs and Lactation Database (...]
    Review Emtricitabine
    . Drugs and Lactation Database (LactMed). 2006
  • Review Interferon Alfa[Drugs and Lactation Database (...]
    Review Interferon Alfa
    . Drugs and Lactation Database (LactMed). 2006
See reviews...See all...

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...